Although Nrf2 activation and the upregulation of CYP1A1 are protective against ROS insult, the significant increase in VSMC migration in our study suggests that the level of ROS generation following PM or PAH treatment may be beyond their protective capacity. The gene discussed is CYP1A1; the disease is pulmonary arterial hypertension.